Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhongkun Liu
Observed name:
Z. Liu
Institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
Observed institutions:
Second Affiliated Hospital of Zhejiang University,
First Affiliated Hospital Zhejiang University,
Zhejiang University
ORCID:
0009-0009-1192-3322
Observed ORCID:
0009-0009-1192-3322
OpenAlex ID:
A5068350215
MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma
2013
·
W. Wang
, H. Lin
, et al.
·
European Journal of Surgical Oncology
·
92
Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2023
·
Wenhua Sang
, Yiduo Zhou
, et al.
·
Cancer Discovery
·
68
Targeting DGAT1 reprograms lipid landscape and restores CD8⁺ T cell immunity in pancreatic cancer
2026
·
Zhongkun Liu
, Lang Chen
, et al.
·
Nature Communications
·
2
Data from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S3 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
SUPPLEMENTARY DATA FIGURES from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S1 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Data from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S4 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Data from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
SUPPLEMENTARY DATA FIGURES from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
PDF
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S3 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S1 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S4 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S1 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S4 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Show more works
View as search
Works count:
19
Citation count:
162
H-index:
2
I10-index:
2
Year
Topic
Type